Mark W Hahn Verona Pharma PLC (VRNA) insider trading activity

Mark W Hahn is Chief Financial Officer of Verona Pharma plc. Currently has a direct ownership of 13.3 Million shares of VRNA, which is worth approximately $890 Million. The most recent transaction as insider was on Aug 07, 2024, when has been sold 800,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.3M

0.25% 3M change

11.34% 12M change

Total Value Held $890 Million

Mark W Hahn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 07 2024	BUY Grant, award, or other acquisition	-	800,000 Added 4.86%	15,654,488 Ordinary Shares
Aug 01 2024	SELL Payment of exercise price or tax liability	$250,579 $2.83 p/Share	88,544 Reduced 0.59%	14,854,488 Ordinary Shares
May 01 2024	SELL Payment of exercise price or tax liability	$170,889 $1.93 p/Share	88,544 Reduced 0.59%	14,943,032 Ordinary Shares
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,100,720 $2.29 p/Share	480,664 Reduced 3.1%	15,031,576 Ordinary Shares
Nov 01 2023	SELL Payment of exercise price or tax liability	$1,407,673 $1.74 p/Share	809,008 Reduced 4.96%	15,512,240 Ordinary Shares
Oct 20 2023	BUY Grant, award, or other acquisition	-	800,000 Added 4.67%	16,321,248 Ordinary Shares
Aug 07 2023	SELL Open market or private sale	$21,281 $2.47 p/Share	8,616 Reduced 0.06%	15,521,248 Ordinary Shares
Aug 04 2023	SELL Open market or private sale	$375,000 $2.5 p/Share	150,000 Reduced 0.96%	15,529,864 Ordinary Shares
Aug 03 2023	SELL Open market or private sale	$297,870 $2.54 p/Share	117,272 Reduced 0.74%	15,679,864 Ordinary Shares
Aug 02 2023	SELL Open market or private sale	$190,893 $2.59 p/Share	73,704 Reduced 0.46%	15,797,136 Ordinary Shares
Aug 01 2023	SELL Open market or private sale	$283,929 $2.68 p/Share	105,944 Reduced 0.66%	15,870,840 Ordinary Shares
May 01 2023	SELL Open market or private sale	$1,175,262 $2.58 p/Share	455,528 Reduced 2.77%	15,976,784 Ordinary Shares
Feb 01 2023	SELL Open market or private sale	$1,057,710 $2.56 p/Share	413,168 Reduced 2.45%	16,432,312 Ordinary Shares
Dec 20 2022	SELL Open market or private sale	$1,272,000 $2.12 p/Share	600,000 Reduced 3.44%	16,845,480 Ordinary Shares
Nov 01 2022	SELL Payment of exercise price or tax liability	$727,769 $1.6 p/Share	454,856 Reduced 2.54%	17,458,640 Ordinary Shares
Nov 01 2022	SELL Open market or private sale	$21,977 $1.67 p/Share	13,160 Reduced 0.08%	17,445,480 Ordinary Shares
Sep 26 2022	BUY Grant, award, or other acquisition	-	3,600,000 Added 16.73%	17,913,496 Ordinary Shares
Aug 09 2022	SELL Open market or private sale	$1,050,000 $1.75 p/Share	600,000 Reduced 4.02%	14,313,496 Ordinary Shares
Aug 01 2022	SELL Open market or private sale	$9,218 $0.7 p/Share	13,168 Reduced 0.09%	14,913,496 Ordinary Shares
Aug 01 2022	SELL Payment of exercise price or tax liability	$304,754 $0.67 p/Share	454,856 Reduced 2.96%	14,926,664 Ordinary Shares
May 03 2022	SELL Open market or private sale	$6,256 $0.5 p/Share	12,512 Reduced 0.08%	15,381,520 Ordinary Shares
May 01 2022	SELL Payment of exercise price or tax liability	$224,707 $0.52 p/Share	432,128 Reduced 2.73%	15,394,032 Ordinary Shares
Feb 02 2022	SELL Open market or private sale	$7,916 $0.76 p/Share	10,416 Reduced 0.07%	15,826,160 Ordinary Shares
Feb 01 2022	SELL Payment of exercise price or tax liability	$224,890 $0.78 p/Share	288,320 Reduced 1.79%	15,836,576 Ordinary Shares
Feb 01 2022	BUY Grant, award, or other acquisition	$100,332 $0.75 p/Share	133,776 Added 0.82%	16,124,896 Ordinary Shares

MWH

Mark W Hahn

Chief Financial Officer

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Verona Pharma plc

Track Activities on VRNA

Account